News

Hims & Hers Health ( NYSE: HIMS) priced its offering of $870M aggregate principal amount of 0.00% convertible senior notes due 2030 in a private offering to persons reasonably believed to be qualified ...
Shares of Hims & Hers Health ( HIMS -5.48%) and LifeMD ( LFMD -14.33%) are surging on Tuesday. The companie' stocks had ...
The latest price target for Hims & Hers Health (NYSE:HIMS) was reported by Piper Sandler on May 6, 2025. The analyst firm set a price target for $39.00 expecting HIMS to fall to within 12 months ...
Hims & Hers Health announces a $450M convertible notes offering to fuel global expansion and acquisitions. Learn about their plans and market impact.